| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A signature of circulating miRNAs predicts the prognosis and therapeutic outcome of taxane/platinum regimen in advanced ovarian carcinoma patients
|
Pal, Ranita
|
|
|
26 |
7 |
p. 1716-1724
|
artikel
|
| 2 |
Bladder-sparing treatment using tislelizumab combined with gemcitabine/cisplatin in selected patients with muscle-invasive bladder cancer: a real-world study
|
Luo, Cheng
|
|
|
26 |
7 |
p. 1759-1767
|
artikel
|
| 3 |
Comparison of the efficacy and safety of anlotinib monotherapy or anlotinib plus immune checkpoint inhibitor for advanced small cell lung cancer with brain metastases
|
Xu, Manyi
|
|
|
26 |
7 |
p. 1687-1695
|
artikel
|
| 4 |
Correction: Surgical margins and prognosis of borderline and malignant phyllodes tumors
|
Su, Jialin
|
|
|
26 |
7 |
p. 1804-1805
|
artikel
|
| 5 |
Criteria and indicators to evaluate quality of care in genitourinary tumour boards
|
Puente, Javier
|
|
|
26 |
7 |
p. 1639-1646
|
artikel
|
| 6 |
Cumulative incidences of hypogonadism, hypertension, and dyslipidaemia in patients with stage I seminoma treated with a risk-adapted strategy: a Spanish single-centre retrospective analysis
|
Tapia, Jose C.
|
|
|
26 |
7 |
p. 1798-1803
|
artikel
|
| 7 |
Current approaches in glioblastoma multiforme immunotherapy
|
Aghajani, Marjan
|
|
|
26 |
7 |
p. 1584-1612
|
artikel
|
| 8 |
Doxorubicin-induced chemoresistance in Duke’s type B colon adenocarcinoma cell line is aggravated in the presence of TGF-β2 through non-apoptotic cell death
|
Sritharan, Sruthi
|
|
|
26 |
7 |
p. 1630-1638
|
artikel
|
| 9 |
Editorial Expression of Concern: miRNA signatures in childhood sarcomas and their clinical implications
|
Viera, G. M.
|
|
|
26 |
7 |
p. 1806
|
artikel
|
| 10 |
Efficacy and safety of a combination treatment of immune checkpoint inhibitors in metastatic breast cancer: a systematic review and meta-analysis
|
Wang, Ying
|
|
|
26 |
7 |
p. 1725-1737
|
artikel
|
| 11 |
Elderly patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors in a multicentre cohort
|
Pla, Helena
|
|
|
26 |
7 |
p. 1748-1758
|
artikel
|
| 12 |
Impact of platinum-based chemotherapy on the tumor mutational burden and immune microenvironment in non-small cell lung cancer with postoperative recurrence
|
Wu, Jianghua
|
|
|
26 |
7 |
p. 1738-1747
|
artikel
|
| 13 |
Insight into the significance of Foxp3 + tumor-infiltrating lymphocytes in squamous cell lung cancer
|
Shiomi, Kazu
|
|
|
26 |
7 |
p. 1708-1715
|
artikel
|
| 14 |
Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON–SEOM registry
|
Arias-Martinez, Aranzazu
|
|
|
26 |
7 |
p. 1674-1686
|
artikel
|
| 15 |
MET overexpression correlated with prognosis of EGFR-mutant treatment‑naïve advanced lung adenocarcinoma: a real‑world retrospective study
|
Wang, Na
|
|
|
26 |
7 |
p. 1696-1707
|
artikel
|
| 16 |
Molecular profile in endometrial carcinoma: can we predict the lymph node status? A systematic review and meta-analysis
|
Luzarraga Aznar, Ana
|
|
|
26 |
7 |
p. 1768-1778
|
artikel
|
| 17 |
Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP
|
Ospina, Aylen Vanessa
|
|
|
26 |
7 |
p. 1647-1663
|
artikel
|
| 18 |
On the need of in vivo verifications as quality control for intraoperative electron radiotherapy in breast cancer
|
Cases, Carla
|
|
|
26 |
7 |
p. 1623-1629
|
artikel
|
| 19 |
Real-world evaluation of first-line treatment of extensive-stage small-cell lung cancer with atezolizumab plus platinum/etoposide: a focus on patients with brain metastasis
|
Chen, Hanxiao
|
|
|
26 |
7 |
p. 1664-1673
|
artikel
|
| 20 |
Safety profile of trastuzumab deruxtecan in advanced breast cancer: Expert opinion on adverse event management
|
Ciruelos, Eva
|
|
|
26 |
7 |
p. 1539-1548
|
artikel
|
| 21 |
SBRT-SG-01: final results of a prospective multicenter study on stereotactic body radiotherapy for liver metastases
|
Rodríguez, María-Carmen Rubio
|
|
|
26 |
7 |
p. 1790-1797
|
artikel
|
| 22 |
Surgical margins and prognosis of borderline and malignant phyllodes tumors
|
Su, Jialin
|
|
|
26 |
7 |
p. 1613-1622
|
artikel
|
| 23 |
The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy
|
Gómez Rueda, Ana
|
|
|
26 |
7 |
p. 1779-1789
|
artikel
|
| 24 |
Towards stronger tobacco control policies to curb the smoking epidemic in Spain
|
Pérez-Ríos, Mónica
|
|
|
26 |
7 |
p. 1561-1569
|
artikel
|
| 25 |
Update on the management of older patients with pancreatic adenocarcinoma: a perspective from medical oncology
|
Guillot Morales, Mónica
|
|
|
26 |
7 |
p. 1570-1583
|
artikel
|
| 26 |
What’s new about the tumor microenvironment of urothelial carcinoma?
|
Coelho, João Queirós
|
|
|
26 |
7 |
p. 1549-1560
|
artikel
|
Tijdschrift beschrijving